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A bile salt hydrolase (BSH) was isolated from Bifidobacterium longum SBT2928, purified, and characterized.
Furthermore, we describe for the first time cloning and analysis of the gene encoding BSH (bsh) in a member
of the genus Bifidobacterium. The enzyme has a native molecular weight of 125,000 to 130,000 and a subunit
molecular weight of 35,024, as determined from the deduced amino acid sequence, indicating that the enzyme
is a tetramer. The pH optimum of B. longum BSH is between 5 and 7, and the temperature optimum is 40°C.
The enzyme is strongly inhibited by thiol enzyme inhibitors, indicating that a Cys residue is likely to be involved
in the catalytic reaction. The BSH of B. longum can hydrolyze all six major human bile salts and at least two
animal bile salts. A slight preference for glycine-conjugated bile acids was detected based on both the specificity
and the Km values. The nucleotide sequence of bsh was determined and used for homology studies, transcript
analysis, and construction and analysis of various mutants. The levels of homology with BSH of other bacteria
and with penicillin V acylase (PVA) of Bacillus sphaericus were high. On the basis of the similarity of BSH and
PVA, whose crystal structure has been elucidated, BSH can be classified as an N-terminal nucleophile
hydrolase with Cys as the N-terminal amino acid. This classification was confirmed by the fact that a Cys1Ala
exchange by site-directed mutagenesis resulted in an inactive protein. Reverse transcription-PCR experiments
revealed that bsh is part of an operon containing at least two genes, bsh and glnE (GlnE is glutamine synthetase
adenylyltransferase). Two UV-induced BSH-negative mutants and one spontaneous BSH-negative mutant were
isolated from B. longum SBT2928 cultures and characterized. These mutants had point mutations that
inactivated bsh by premature termination, frameshift, or amino acid exchange.
Bifidobacteria are important components of the human in-
testinal microflora, in which they occur at concentrations of 109
to 1010 cells/g of feces (45), and of fermented milk products, to
which they are added mainly because of their supposed health-
promoting activities (2, 20). However, molecular genetic re-
search on bifidobacteria is still in its infancy. In addition to
many 16S rRNA sequences, only six genes (see Table 6) and
two plasmids of members of the genus Bifidobacterium have
been cloned and sequenced. Only recently has development of
cloning vectors and transformation techniques started (19).
One important metabolic activity which is exhibited by al-
most all bifidobacteria is deconjugation of bile salts, which
occurs naturally in the intestines of humans (44). The respon-
sible enzyme, bile salt hydrolase (BSH) (cholylglycine hydro-
lase; EC 3.5.1.24), catalyzes the hydrolysis of glycine- and/or
taurine-conjugated bile salts into amino acid residues and de-
conjugated bile salts (bile acids). The function of this enzyme
in the producing bacterium is not known, although various
observations have been made and various theories about its
role in the producer have been proposed; these theories in-
clude a role in utilization of the liberated amino acid or a role
in increased resistance to the toxic levels of bile salts in the
gastrointestinal environment (10). A recent screening analysis
of more than 300 lactic acid bacterial strains performed in our
laboratory showed that BSH activity is found primarily in or-
ganisms isolated from the gastrointestinal tracts of mammals
(Bifidobacterium spp., Lactobacillus acidophilus, Lactobacillus
gasseri, Lactobacillus johnsonii, some strains of Lactobacillus
plantarum), while organisms isolated from fermented milk
preparations and vegetables (Lactococcus lactis, Lactobacillus
delbrueckii, Lactobacillus helveticus, Streptococcus thermophi-
lus) do not exhibit BSH activity (44).
In a mammalian host deconjugation of bile salts takes place
in the small and large intestines. The exact location of this
process depends on the distribution of the bacterial flora in the
host species; for example, in mice a Lactobacillus flora is
present in the small intestine, while in humans a significant
flora starts only at the end of the ileum and is fully developed
in the large intestine. This means that bile salt deconjugation in
mice starts in the small intestine (47), while significant decon-
jugation in humans begins at the end of the ileum and is
completed in the large bowel (28, 34). The function of bile salt
deconjugation in mammalian hosts is also not understood.
However, in experiments performed with germfree and con-
ventional mice, it has been observed that the presence of a
microflora increases bile acid excretion and decreases serum
cholesterol levels (5, 45). More is known about the adverse
effects of bile salt metabolism, such as extensive deconjugation
of bile salts in the small bowel in humans, which leads to
steatorrhoea. Furthermore, enhanced concentrations of sec-
ondary bile acids in the colon can have tumor-promoting ef-
fects (29).
So far, BSH has been isolated from Bacteroides fragilis subsp.
fragilis (41), Clostridium sp. (13), Lactobacillus sp. (25), and
Bifidobacterium longum (15) and characterized. The bsh genes
of Clostridium perfringens (7), L. plantarum (6) and L. johnsonii
(11) have been cloned and sequenced, and BSH-negative mu-
tants of L. plantarum (24) and Lactobacillus sp. (46) have been
constructed.
In recent years the possibility of using bile salt deconjugation
by lactic acid bacteria to lower serum cholesterol levels in
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hypercholesterolemic humans or to prevent hypercholesterol-
emia in individuals with normal cholesterol levels has received
increased attention (8, 9). This possibility is surrounded by
controversy concerning its validity and the mechanisms in-
volved (28). To resolve the questions, a mechanistic approach
which works with defined bacterial strains and can be used to
investigate the effect of BSH in experimental animals and in
humans is necessary. To create a basis for this investigation, we
isolated and purified the BSH of B. longum SBT2928, a strain
which has been isolated from human feces and which exhibits
very high BSH activity. We cloned the BSH gene of this strain
and selected and characterized a number of mutants, including
a spontaneous BSH-negative strain. The latter strain could be
used as a negative control in both animal experiments and
human studies without the regulatory problems usually en-
countered with strains constructed by genetic engineering tech-
niques.
MATERIALS AND METHODS
Strains, plasmids, and media. The strains and plasmids used in this study are
listed in Table 1. The strains were stored in 20% glycerol at 250°C. Escherichia
coli was grown in TY medium (37) at 37°C with vigorous agitation or on TY
medium solidified with 1.5% agar. For kanamycin resistance selection 50 mg of
kanamycin per ml was added to the media. B. longum was grown in Briggs Liver
Broth (3), which was prepared as follows. Tomato juice was mixed with an equal
volume of distilled water and steamed for 1.5 h. Then the pH was adjusted to 7.0
with 2.5 M NaOH, and the preparation was filtered through a paper filter. Liver
extract was prepared by using Bacto Liver (Difco Laboratories, Detroit, Mich.).
Ten grams of liver powder was extracted with 170 ml of distilled water at 50 to
60°C for 1 h and then heated for 2 to 3 min at 100°C. After the preparation
cooled, the pH was adjusted to 7.0, and the resulting extract was filtered through
a paper filter. To prepare a 100-ml ascorbate-cysteine solution, 0.2 g of L-cysteine
and 34 g of ascorbate were dissolved in water, and the pH was adjusted to 7.0 by
adding ca. 11 g of sodium carbonate. The base medium was prepared as de-
scribed by Briggs (3), and 75 ml of liver extract was added per 1,000 ml of
medium. Shortly before the culture was started, 15 ml of the ascorbate-cysteine
solution was added per 1,000 ml of medium. The strains were grown in liquid
cultures at 37°C under anaerobic conditions (airtight containers with AnaeroGen
AN35 bags, [Oxoid, Hampshire, United Kingdom]) for 16 to 20 h and on agar
plates for 48 h. Alternatively, especially in the genetic experiments, M17 medium
(48) supplemented with 1% glucose and 2.5 mM L-cysteine was used, and cells
were grown as described above. To select mutants, M17 agar (1.5% agar) sup-
plemented with 0.5% lactose and 15 ml of the ascorbate-cysteine solution per
1,000 ml of agar was used as the base medium and as the overlay agar for BSH
activity detection.
Preparation of cell extracts. Cells in an overnight culture were sedimented by
centrifugation for 10 min at 10,000 3 g and 4°C, washed twice in 0.1 M sodium
phosphate buffer (pH 7.0), and resuspended in the same buffer to give a density
of approximately 10 to 15 optical density units at 600 nm (path length, 1 cm). To
reduce oxidation of the enzyme, 10 mM dithiothreitol (DTT) was routinely
added. Seven milliliters of the cell suspension was sonicated (Vibracell; Sonics &
Materials, Danbury, Conn.) for 3 min at level 5 by using a 50% duty cycle and
constant cooling. To remove residual DNA, 1% streptomycin sulfate and 0.1%
polyethylenimine were added, and the suspension was stirred for 15 min. Then
the mixture was centrifuged for 10 min at 20,000 3 g and 4°C. The supernatant
was stored as a cell extract at 220°C.
BSH assay and protein assay. A fast BSH assay was carried out as described
by Coleman and Hudson (7), with several modifications. Portions (10 to 20 ml)
of cell extract or partially purified BSH were added to wells of a 96-well micro-
titer plate with a flat bottom, and 200 ml of reaction mixture (50 mM sodium
phosphate, 10 mM DTT, 1 mM EDTA, 10 mM sodium glycodeoxycholate; pH
5.5) was added. To ensure that the reaction conditions were (semi)anaerobic and
to prevent evaporation during longer incubations, the wells were overlaid with 50
ml of light paraffin oil (0.85 g/ml; Merck, Darmstadt, Germany). Precipitation of
deoxycholic acid was monitored with a microtiter plate reader (model 3550-UV
microplate reader; Bio-Rad, Hercules, Calif.) at 37°C. The time until precipita-
tion was an indication of the enzyme activity in the sample.
BSH activity was determined routinely with a two-step assay by determining
the amounts of the amino acids liberated from conjugated bile salts. To 180 ml
of reaction buffer (0.1 M sodium phosphate, pH 6.0), 10 ml of appropriately
diluted sample and 10 ml of a human bile salt mixture (200 mM) (16, 40) (12%
taurocholic acid, 12% taurochenodeoxycholic acid, 8% taurodeoxycholic acid,
23% glycocholic acid, 23% glycochenodeoxycholic acid, 16% glycodeoxycholic
acid) were added. The bile salt mixture was used in order to measure the overall
activity of BSH with human bile salts. To determine the substrate specificity and
Km values, individual bile salts (final concentration, 10 mM) were used. In some
cases 10 mM DTT was added to the reaction mixture. Reactions were carried out
TABLE 1. Strains and plasmids
Strain or plasmid Propertiesa Reference or source
Strains
B. longum SBT2928 Wild type, isolated from human feces Snow Brand Milk Products Co., Ltd.,
Kawagoe, Japan
B. longum SBT2928 mutant A3 Spontaneous BSH-negative mutant This study
B. longum SBT2928 mutant 2001 UV-induced BSH-negative mutant This study
B. longum SBT2928 mutant 2503 UV-induced BSH-negative mutant This study
E. coli TOP10 F2 mcrA D(mrr-hsdRMS-mcrBC) f80lacZDM15
DlacX74 deoR recA1 araD139 D(ara-leu)7697
galU galK rpsL endA1 nupG
Invitrogen Corp., Carlsbad, Calif.




pUK21 Kmr, multipurpose cloning vector 55
pCR-Blunt Kmr, blunt end cloning vector Invitrogen Corp., Carlsbad, Calif.
pBH13 Kmr, 2.7-kb insert of the chromosome of B.
longum SBT2928, confers BSH activity
This study
pBH16 Kmr, 8-kb insert of the chromosome of B. longum
SBT2928, confers BSH activity
This study
pBH1322 1.2-kb fragment of pBH13 cloned in pCR-Blunt This study
pBH1351 1.5-kb fragment of pBH13 cloned in pCR-Blunt,
confers BSH activity
This study
pCR-A3 bsh region obtained by PCR of bsh of B. longum
SBT2928 mutant A3 cloned into pCR-Blunt
This study
pCR-2001 bsh region obtained by PCR of bsh of B. longum
SBT2928 mutant 2001 cloned into pCR-Blunt
This study
pCR-2503 bsh region obtained by PCR of bsh of B. longum
SBT2928 mutant 2503 cloned into pCR-Blunt
This study
pCA-1 pBH1351 with Cys-1–to–Ala mutation This study
a Kmr, kanamycin resistance.
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at 37°C. Samples (50 ml) were removed after 10 and 30 min of incubation and
mixed immediately with 50 ml of 15% (wt/vol) trichloroacetic acid. Subsequently,
the samples were centrifuged at the highest speed with a table top centrifuge
(model 5417 C; Eppendorf, Hamburg, Germany) to remove the precipitate. For
the second reaction (22), an aliquot of the first reaction mixture was mixed with
water to obtain a volume of 100 ml (usually 20 ml of sample and 80 ml of water).
To this mixture 1.9 ml of ninhydrin reagent (0.5 ml of 1% [wt/vol] ninhydrin in
0.5 M citrate buffer [pH 5.5], 1.2 ml of glycerol, 0.2 ml of 0.5 M citrate buffer; pH
5.5) was added, and the preparation was thoroughly mixed and boiled for 14 min.
Then the tube was cooled for 3 min in tap water, and the absorbance at 570 nm
was determined. A standard curve was prepared for each assay by using either
glycine or taurine. If DTT was present in the first reaction mixture, then the same
amount of DTT was added when the standard curve was prepared. One unit of
BSH activity was defined as the amount of enzyme which liberated 1 mmol of
amino acids from the substrate per minute.
Protein concentrations were determined with the Bio-Rad Protein Assay;
bovine serum albumin was used as the standard.
Chromatography methods. MonoQ anion-exchange chromatography (MonoQ
HR5/5; Pharmacia Biotech, Uppsala, Sweden) was carried out as described by
Grill et al. (15), with the following modifications. The solvent used was 0.1 M
sodium phosphate buffer (pH 7.0), and the elution buffer was 0.1 M sodium
phosphate (pH 7.0) to which 1 M NaCl was added, which resulted in a pH of 6.5.
After proteins were loaded onto the column, they were eluted with a 0 to 0.5 M
NaCl gradient in 20 min by using a flow rate of 1 ml/min. One-milliliter fractions
were collected.
MonoS cation-exchange chromatography was performed with a MonoS HR5/5
column (Pharmacia Biotech). The solvent used was 0.05 M sodium acetate (pH
5.0), and the elution buffer was 0.05 M sodium acetate–1 M NaCl (pH 5.0). The
flow rate was 1 ml/min. Prior to chromatography the pooled MonoQ fractions
that exhibited BSH activity were diluted 1:4 with the solvent, and the pH was
adjusted to 5.0.
Gel filtration was carried out with a Superose 12HR 10/30 column (Pharmacia
Biotech). The solvent used was 0.1 M sodium phosphate–0.15 M NaCl (pH 7.0),
and the flow rate was 0.5 ml/min. For this chromatography analysis the proteins
were concentrated, and the buffer was exchanged by using Microcon10 microcon-
centrators (Amicon, Berkeley, Calif.).
Gel filtration with high-performance liquid chromatography (HPLC) (Phar-
macia, Biotech) was carried out by using a SigmaChrom GFC-1300 column (300
by 7.5 mm; Supelco, Bellefonte, Pa.). The mobile phase used was 0.1 M sodium
phosphate buffer (pH 7)–0.15 M NaCl, the flow rate was 0.5 ml/min, and chro-
matography was carried out at 4 or 21°C. A molecular weight standard kit
(MW-GF-1000) was obtained from Sigma Chemical Co. (St. Louis, Mo.).
In all chromatography experiments absorption at 280 nm was monitored dur-
ing elution. To identify BSH activity in the fractions, the microtiter plate assay
was used. Quantitative determinations were carried out by using the ninhydrin
assay (see above).
Immunostaining of BSH with anti-C. perfringens BSH antibodies. Anti-C.
perfringens BSH antibodies were a kind gift from J. P. Coleman of East Carolina
University (7). After a preparation was blotted onto a polyvinylidene difluoride
(PVDF) membrane by using the Mini-blot system (Bio-Rad) (49), the membrane
was immunostained with a Proto Blot II kit (Promega, Madison, Wis.) by fol-
lowing the manufacturer’s instructions. The first antibody was diluted 1:2,000.
Determination of native and subunit molecular weights. The native molecular
weight was determined by gel chromatography with HPLC; triplicate prepara-
tions were chromatographed at 21 or 4°C. The subunit molecular weight was
determined by performing four independent sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (PAGE) analyses (21) in which low-molecu-
lar-weight standard proteins (Bio-Rad) were used.
Determination of the pH and temperature optima for BSH activity. The BSH
activity that was purified with consecutive MonoQ and MonoS chromatography
steps was determined between pH 3 and pH 9 under standard conditions (see
above) without DTT. The following buffers were used: 0.1 M sodium citrate-
sodium phosphate buffer (pH 3 to 5); 0.1 M sodium phosphate buffer (pH 5.5 to
8); and 0.1 M sodium citrate-sodium phosphate buffer (pH 9).
The temperature optimum was determined in 0.1 M sodium phosphate buffer
at pH 6.0 by using the standard reaction mixture (see above) without DTT.
Determination of the pH and temperature stability of BSH. We examined the
stability of BSH at different pH values by using the buffers mentioned above at
pH 3 to 10. The pH 10 buffer was prepared with 0.1 M sodium borate. Samples
were incubated at the different pH values for 30 min at 37°C, and then the
residual activity was determined at pH 6 by using the ninhydrin method without
DTT.
The temperature stability of the enzyme was determined at temperatures
ranging from 4 to 60°C. BSH was incubated at the different temperatures for 30
min, and the residual activity was determined by the standard assay in the
absence of DTT (see above).
Inhibition and activation of the enzyme. Inhibition or activation was studied by
using the following compounds: iodoacetate, N-ethylmaleimide, periodic acid,
EDTA, phenylmethylsulfonyl fluoride (dissolved in 70% ethanol), para-chloro-
mercuribenzoic acid (dissolved in dimethyl sulfoxide), MgCl2, MgSO4, HgCl2,
CaCl2, CuCl2, and NaCl. Because some of these substances interact with phos-
phate, 20 mM MES (morpholineethanesulfonic acid) buffer (pH 6) was used for
this part of the study. Before the substrate was added, the enzyme was incubated
for 30 min at 37°C with the compounds mentioned above. Then the standard
enzyme assay was carried out to determine the residual enzyme activity.
Determination of the N-terminal amino acid sequence. BSH was purified by
consecutive MonoQ and MonoS chromatography steps. The resulting fractions
that exhibited BSH activity were combined, concentrated, and applied to a mini
electrophoresis unit (Bio-Rad). After separation, the proteins were electroblot-
ted onto a PVDF membrane (Bio-Rad) and stained with Coomassie brilliant
blue R-250 by using the method of Matsudaira (30), and the BSH protein was cut
out and used for sequencing. N-terminal amino acid sequencing was performed
with a Perkin-Elmer/Applied Biosystems model 476A protein sequencer (Perkin-
Elmer/Applied Biosystems, Foster City, Calif.).
General genetic techniques, DNA sequencing, and sequence analysis. B. lon-
gum DNA was isolated by the method of Leenhouts et al. (23), with several
modifications. The cells in 1.5 ml of an overnight culture were sedimented,
washed once with distilled water, and resuspended in 20% sucrose–10 mM
Tris-HCl (pH 8.1)–10 mM EDTA–50 mM NaCl containing 5 mg of lysozyme per
ml. After incubation at 55°C for 10 min, first 20 ml of proteinase K (20 mg/ml)
and then 25 ml of 10% SDS were added, and the suspension was mixed gently by
inversion. The mixture was incubated at 60°C for at least 1 h to obtain complete
lysis. The lysate was cleared by several phenol-chloroform extraction steps, and
the DNA was precipitated by using standard methods. After the ethanol was
removed without drying, the pellet was dissolved in 200 ml of 10 mM Tris-HCl
(pH 7.4)–1 mM EDTA, and 5 ml of RNase (10 mg/ml) was added. The method
could easily be scaled up for a culture volume of 15 ml.
A bank of B. longum SBT2928 chromosomal DNA fragments was constructed
as described by Buist et al. (4) by using the vector pUK21 (55). E. coli NM522
(14) was transformed by electroporation as described by Zabarovsky and Win-
berg (57). BSH-positive clones were detected on TY agar plates containing 2%
glucose and 3 mM glycodeoxycholic acid (7). General cloning procedures were
performed essentially as described by Sambrook et al. (38).
Nucleotide sequences were determined by using dye primers, the cycle se-
quencing method (33), and a type RPN 2538 Thermosequenase (43) kit obtained
from Amersham-Pharmacia (Uppsala, Sweden). Samples were analyzed with an
TABLE 2. Primers used for PCR
Primer Sequence (59 to 39) Use
A CTG CCA CCT GTA TTC GA Amplification of mutant bsh and RT-PCR
B AGC ACT GGT GTC CGT TTC T RT-PCR
C GAC CTC GTC GAC GGA GT RT-PCR
D GCC TCG TTC GTC CAC GA RT-PCR
E TTG CTC AAT GCC ATA TC Amplification of mutant bsh and RT-PCR
F CGG ACA CCA GTG GAC AT RT-PCR
ALA GCC ACT GGT GTC CGT TTC Ta Cys-1–to–Ala mutation primer
SAL GAC CTC GTC GAC GGA GTb Primer with SalI site for SDMd
ATG CAT AAC GGA CTC CCT TCc Primer with ATG for SDMd
FW GTA AAA CGA CGG CCA G Standard 220 forward primer
a The boldface type indicates nucleotide changes.
b The boldface type indicates an SalI site.
c The boldface type indicates a complementary sequence for the ATG start codon.
d SDM, site-directed mutagenesis.
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A.L.F.-Express sequencing robot (Amersham-Pharmacia). The nucleotide se-
quencing experiments were carried out at Pathology-Laboratory Medicine, Lab-
oratory of Molecular Biology, University of Groningen, Groningen, The Neth-
erlands.
The nucleotide sequence obtained was analyzed with the PC/Gene sequence
analysis program (IntelliGenetics, Inc., Geneva, Switzerland) and different In-
ternet online tools as described below.
Plasmid construction. To construct pBH1322 and pBH1351, pBH13 was cut
with EcoRV and Asp718, the overhanging ends were filled in with the Klenow
polymerase, and the fragments were separated in and isolated from an agarose
gel and then cloned into the blunt end cloning vector pCR-Blunt (Invitrogen,
Carlsbad, Calif.). The BSH regions of mutant strains were amplified by PCR
performed with PWO polymerase (Roche Diagnostics Nederland b.v., Almere,
The Netherlands) and appropriate primers and cloned into pCR-Blunt (Invitro-
gen).
Cys-1 was exchanged for Ala by using a PCR-based site-directed mutagenesis
method and pBH1351 as the template. The first DNA fragment, starting at
codon 2 of bsh, was amplified with primers ALA and SAL, while the second bsh
fragment, ending at codon 1, was amplified with primers ATG and FW (Table 2).
The high-fidelity PWO polymerase (Roche Diagnostics Nederland) was used in
both cases, and the PCR fragments were purified with a High Pure PCR product
purification kit (Roche Diagnostics Nederland). After purification, the two PCR
products were phosphorylated and cut with SalI and XbaI, respectively. Plasmid
pBH1351 was cut with SalI and XbaI, and the large fragment was purified and
ligated with both PCR products. The bsh gene in the resulting plasmid, pCA-1,
was examined by nucleotide sequencing to determine whether mutations other
than those expected (Cys-1-Ala) as a possible result of the PCR were present. No
such changes were detected.
PCR and RT-PCR. Table 2 shows the primers which were used in PCR and/or
reverse transcription PCR (RT-PCR). Each PCR was carried out by using PWO
polymerase as recommended by the manufacturer (Roche Diagnostics Neder-
land). RNA was isolated by using the macaloid method described by van Assel-
donk et al. (50). First-strand cDNA synthesis was carried out with a first-strand
cDNA synthesis kit (Roche Diagnostics Nederland) as recommended by the
manufacturer by using either primer C or primer E (Table 2 and Fig. 1). Sub-
sequently, PCRs were carried out by using Taq polymerase (HT Biotechnology,
Ltd., Cambridge, United Kingdom), appropriate primer pairs, and both cDNAs.
Selection of spontaneous and UV-induced BSH-negative mutants. A sponta-
neous BSH-negative mutant was isolated during development of a selection
procedure for detection of UV-induced bsh mutants. An M17 agar plate con-
taining B. longum SBT2928 colonies was overlaid with M17 agar containing 0.5%
lactose, 15 ml of a cysteine-ascorbate solution per liter, and 5 mM glycodeoxy-
cholic acid. One BSH-negative colony which did not produce a precipitation halo
was detected, and the organism was purified.
To select UV-induced mutants, a preculture was grown overnight in M17
medium supplemented with 0.5% lactose and 15 ml of a cysteine-ascorbate
solution per liter, diluted 100-fold, and grown to a density of about 2 3 108
cells/ml. The cells were washed twice in 10 mM sodium phosphate–0.138 M NaCl
(pH 7.4) and resuspended to a density of about 2 3 108 cells/ml. A 1026 dilution
was plated to determine the total number of viable cells. Subsequently, 12-ml
portions were pipetted into a 140-mm glass petri dish and irradiated from a
distance of 25 cm for 1, 1.5, 2, and 2.5 min with 250-nm UV light (model LS-88
lamp; Raytech Industries, Inc., Staffold Springs, Conn.) with shaking (30 rpm).
Aliquots were plated directly to calculate survival rates, while 0.5 ml of irradiated
cells was transferred into 10 ml of M17 medium and allowed to grow for 2 h.
Then the cultures were plated, and approximately 350 to 1,000 colonies per
140-mm plate were obtained. The plates were incubated anaerobically for 48 h
and then overlaid with M17 agar containing 2.5 mM glycodeoxycholic acid (see
above).
Nucleotide sequence accession number. The bsh nucleotide sequence has been
deposited in the GenBank database under accession number AF148138.
RESULTS
Isolation and purification of B. longum BSH. B. longum
SBT2928 was selected during a broad screening analysis of
lactic acid bacteria (44) because of its high level of BSH activ-
ity. Since no major differences in enzyme activity during dif-
ferent growth phases or in the presence and in the absence of
a 0.1 mM bile salt mixture (see Materials and Methods) were
observed (results not shown), BSH was routinely isolated from
overnight cultures grown in Briggs Liver broth.
In preliminary experiments in which cell extracts were used,
we observed that adding 10 mM DTT during sonication im-
proved the yield of BSH activity up to 10-fold. To investigate
this effect, additional cell suspensions were sonicated with and
without 10 mM DTT, after which BSH activity was assayed
with and without 10 mM DTT. Table 3 clearly shows that a lack
of DTT during both sonication (3 min) and the enzyme assay
resulted in ninefold-lower enzyme activity than the activity in a
cell extract prepared with DTT and examined in the presence
of DTT. If a preparation was sonicated without DTT and DTT
was added only during the assay, activity was reduced twofold,
indicating that some of the enzyme activity was not lost and
could be recovered by adding the thiol reagent. If the length of
sonication was extended to 9 min, the amount of residual
activity decreased further, and the amount of enzyme activity
which could be recovered by adding DTT decreased from 50 to
35%. Because of its stabilizing effect, DTT was added during
preparation of cell extracts in all subsequent experiments.
FIG. 1. Genetic and transcriptional organization of the bsh site (A) and
RT-PCR analysis of the transcript of the bsh region (B and C). Pbsh, putative bsh
promoter; A through E, primers A through E used for RT-PCR (Table 2);
MWM, molecular weight marker; DNA, control reaction; 1AMV, first-strand
reaction with AMV; 2AMV, first-strand reaction without AMV. (B) First-strand
cDNA synthesis with primer E. (C) First-strand cDNA synthesis with primer C.
In the lanes in which primers A and C were used and in the lanes in which
primers A and F were used three times as much RT-PCR product was applied in
order to obtain bands whose intensity was similar to that of the DNA control.
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To purify BSH, a cell extract was first applied to a MonoQ
HR column. BSH activity eluted at NaCl concentrations be-
tween 0.33 and 0.36 M. Subsequently, the pooled BSH-con-
taining MonoQ fractions were applied to a MonoS HR col-
umn. BSH appeared in the breakthrough fraction. This
fraction, in which only a few major proteins were still present
(Fig. 2A), was used for further characterization. The level of
BSH activity in the MonoS fraction was 20.5 U/mg; the enzyme
was purified 21-fold, and the yield was 17%.
The BSH protein was identified by using gel filtration (Fig.
2A) combined with immunostaining with anti-C. perfringens
BSH antibodies (Fig. 2B) and N-terminal amino acid sequenc-
ing. An approximately 37-kDa protein was evident throughout
the different chromatography steps, and this protein formed
the major band after gel filtration. Immunostaining revealed
only this band after MonoQ chromatography. N-terminal
amino acid sequencing of the protein in this band resulted in
the following sequence: XTGVRFSDDEGNTYFGRNLDWS
FSYGETIL. A protein homology comparison revealed that
this sequence exhibited very high levels of homology to the
N-terminal amino acid sequences of C. perfringens BSH and
the BSH of various lactobacilli (Fig. 3).
Biochemical characterization of B. longum BSH. SBT2928
BSH is an enzyme that has a broad substrate range and can
hydrolyze not only human bile salts but also tauroursodeoxy-
cholic acid (3a, 7b-OH) and taurohyodeoxycholic acid (3a,
6a-OH) (Table 4). The highest levels of activity were observed
with glycochenodeoxycholic acid (defined as 100% activity)
and with glycine-conjugated bile acids. Furthermore, the en-
zyme exhibited a slight preference for conjugated chenodeoxy-
cholic acid over conjugated cholic and deoxycholic acid. The
substrate specificity of the purified enzyme and the BSH activ-
ity in the cell extract were the same (results not shown). Of the
six major human bile salts tested (Table 4), the enzyme exhib-
ited the highest affinity for glycochenodeoxycholic acid and, in
general, higher affinities for glycine-conjugated bile acids than
for taurine-conjugated bile acids. This is in good agreement
with the results of the substrate specificity analysis.
The pH optimum for BSH activity at 37°C was between pH
5 and 7, and maximum activity occurred at pH 6. Maximum
enzyme activity occurred at temperatures between 40 and
45°C. The enzyme was stable at pH values from 4 to 8; at pH
values above 8 and below 4 it was rapidly inactivated. The
enzyme was stable at temperatures from 4 to 37°C. During 30
min of incubation at 40°C, about 20 to 30% of the activity was
lost, and at 50°C only 20% of the activity was retained. There-
fore, the temperature used for the activity assays was 37°C in
order to prevent loss of enzyme activity during the reactions.
The effects of ions and enzyme inhibitors are summarized in
Table 5. The enzyme was strongly inhibited by five substances
known as SH enzyme inhibitors. Little inhibition was observed
with either a metal enzyme inhibitor (EDTA) or a serine en-
zyme inhibitor (phenylmethylsulfonyl fluoride). Inhibition by
HgCl2 could be reversed by adding a sufficient amount of the
reducing reagent DTT (data not shown). From these results we
concluded that B. longum BSH is probably an SH enzyme.
Therefore, a cysteine residue(s) with a free SH group should
play an important role in the activity of the enzyme (see be-
low). Surprisingly, magnesium sulfate inhibited the enzyme
very strongly, while magnesium chloride did not.
The native molecular weight of BSH was determined by gel
filtration in triplicate at both 4 and at 21°C and was found to be
between 125,000 and 130,000. The subunit molecular weight,
as determined in four independent SDS-PAGE analyses, was
37,300 (Fig. 2), which is in good agreement with the genetic
data (see below) and indicates that the native enzyme is a
tetramer.
Construction of a gene bank for B. longum SBT2928 and
isolation of the BSH gene. A gene bank of the chromosome of
B. longum SBT2928 was constructed in plasmid pUK21 and
was transferred into E. coli NM522 (see Materials and Meth-
ods). A total of 30,000 colonies of transformants were plated
onto BSH selection agar. Two colonies which produced a white
FIG. 2. Purification and immunostaining of B. longum BSH. (A) SDS-PAGE (10% polyacrylamide) after silver staining. Lane MW, molecular weight marker; lane
CFE, cell extract; lanes Q, S, and GF, BSH active fraction after MonoQ chromatography, MonoS chromatography, and gel filtration, respectively. (B) Immunostaining
with anti-C. perfringens BSH antibodies. Lane CFE, cell extract; lanes Q, S, and GF, BSH active fraction after MonoQ chromatography, MonoS chromatography, and
gel filtration, respectively; lanes P and N, cell extract of E. coli with and without C. perfringens BSH, respectively.
TABLE 3. Effect of DTT on BSH activity after sonication of












U/ml % U/mg %
3 2DTT 2DTT 1.04 12 0.89 1.17 11
2DTT 1DTT 4.6 55 0.89 5.2 50
1DTT 2DTT 9.8 112 0.83 11.8 112
1DTT 1DTT 8.7 100 0.83 10.5 100
9 2DTT 2DTT 0.47 4 1.61 0.3 4
2DTT 1DTT 3.9 37 1.61 2.4 35
1DTT 2DTT 10.8 103 1.57 6.9 103
1DTT 1DTT 10.5 100 1.57 6.7 100
a 2DTT, no DTT present; 1DTT, 10 mM DTT present.
b The level of activity in the presence of 10 mM DTT after sonication in the
presence of 10 mM DTT was defined as 100%.
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precipitation halo after 2 to 3 days were identified. The plas-
mids in the cells in these colonies were designated pBH13 and
pBH16 and used for further analysis. The inserts of both plas-
mids were analyzed with various restriction enzymes. pBH13
had a 2.7-kb insert, and pBH16 had a 8-kb insert (Fig. 4). Using
the EcoRV site of the insert in pBH13, we constructed two
subclones, pBH1351 (1.5-kb insert) and pBH1322 (1.2-kb in-
sert) (Fig. 4). As E. coli(pBH1351) was positive in BSH activity
assays, either most or all of the BSH genetic information was
present on the 1.5-kb insert of this clone.
Nucleotide sequencing and analysis. The nucleotide se-
quence of the insert in pBH13 comprises 2,604 bases. In this
sequence one complete open reading frame (ORF) and one
partial ORF were detected, and these ORFs could encode a
317-amino-acid protein and a 447-amino-acid partial protein,
respectively (Fig. 1A and 5). The complete ORF was present in
the pBH1351 insert. The N-terminal amino acid sequence of
the deduced 317-amino-acid protein starting from the third
amino acid was identical to the N-terminal amino acid se-
quence determined by using purified BSH (Fig. 5). These data
show that the complete ORF encodes BSH, and, accordingly,
the gene was designated bsh. Taking into account the fact that
f-Met was processed, the deduced protein had a molecular
weight of 35,024 and a pI of 4.51. The derived molecular
weight is in good agreement with the molecular weight ob-
tained from the biochemical characterization of the enzyme.
The N terminus of the deduced protein did not contain a
typical leader peptide (56) or a membrane-spanning domain.
Screening of the sequence upstream of bsh for promoter
consensus sequences revealed a 210 sequence in which five of
the six bases were conserved (Fig. 5). No 235 sequence was
identified, but a number of direct and inverted repeats present
in the region around 235 could be involved in transcription
initiation (17, 32). Furthermore, a stem-loop structure with a
free energy of 224.5 kcal was detected upstream of bsh. This
structure could have been a rho-independent terminator. How-
ever, the canonical T stretch was missing, indicating that the
stem-loop structure could also have a different function.
No canonical gram-positive Shine-Dalgarno (SD) sequence
(GGAGG [54]) was found upstream of bsh. Since very little is
known about translation initiation in bifidobacteria, the six
genes from members of this genus that have been sequenced
(Bifidobacterium breve b-D-glu [35]; B. longum ldh [31]; all
other gene sequences are available only from GenBank [ac-
cession numbers are shown in Table 6]) were examined for
regions of complementarity upstream of the ATG start codon
with the 39 ends of 16S rRNA of bifidobacteria (as determined
from 16S rRNA sequences in the GenBank database [data not
shown]). Table 6 shows that the location of a core AGG motive
which extended in either the 59 direction or the 39 direction
could be determined. The free energies of the different SD
sequences ranged from 211.8 to 219.4 kcal when single-base
gaps were allowed. Using this approach, we identified two
possible SD sequences upstream of BSH, and these sequences
had free energies of 212.4 and 221.6 kcal (Fig. 5 and Table 6).
Downstream of bsh a stem-loop structure which lacked the
poly(T) stretch was probably not a rho-independent terminator
but could have a different as-yet-unknown function. Further-
more, 55 bases downstream of the stop codon of bsh a new
putative gene, glnE (see below), started. Therefore, bsh could
be transcriptionally coupled to glnE (see below).
The G1C content of the fragment which we sequenced was
62%, which is in good agreement with the G1C range for
bifidobacterial DNA (55 to 67%) (39) and with the G1C
content reported previously for B. longum (62%) (Codon Us-
age Tabulated from GenBank at http://www.dna.affrc.go.jp/
;nakamura/CUTG.html).
Homology studies with B. longum BSH. A BlastX search (1)
revealed high levels of homology between B. longum BSH and
BSH of several Lactobacillus species (37 to 48% identity)
(GenBank accession number AF091248 [6, 11]), as well as C.
perfringens BSH (36% identity) (7), penicillin V acylase (PVA)
of Bacillus sphaericus (30% identical amino acids) (36), and a
hypothetical protein of Bacillus subtilis (29% identity) (GenBank
accession number P54948). Recently, the crystal structure of
the PVA was elucidated (42). The amino acids of the active site
were identified as Cys-1, Asp-20, Tyr-82, Asn-175, and Arg-
228. A comparison of the deduced amino acid sequences of B.
longum BSH and other BSH with the deduced amino acid
sequence of the PVA showed that except for Tyr-82 all of these
amino acids are conserved (Fig. 3).
The deduced product of the second (partial) ORF exhibited
high levels of homology with glutamine synthetase adenylyl-
transferases (GlnE) of Mycobacterium tuberculosis (GenBank
accession number Z70692) (40% identical amino acids in do-
main A and 30% identical amino acids in domain B), E. coli
(GenBank accession number AE000387) (24% identical amino
acids in domain A and 25% identical amino acids in domain
B), and various other bacteria.
bsh and glnE are transcriptionally coupled. In order to ex-
amine whether bsh and glnE are transcriptionally coupled,
total RNA was isolated from B. longum SBT2928, and RT-
PCR was carried out with several primer pairs that probed
TABLE 4. Relative activity and Km values of B. longum
BSH with various bile salts
Substrate (2OH positions)a Relative activity (%) Km (mM)
GCA (3a, 7a, 12a) 85 0.16
GDCA (3a, 12a) 91 0.28
GCDCA (3a, 7a) 100 0.13
TCA (3a, 7a, 12a) 43 1.12
TDCA (3a, 12a) 29 0.79
TCDCA (3a, 7a) 51 0.33
THDCA (3a, 6a) 11 NDb
TUDCA (3a, 7b) 19 ND
a GCA, glycocholic acid; GDCA, glycodeoxycholic acid; GCDCA, glycoche-
nodeoxycholic acid; TCA, taurocholic acid; TDCA, taurodeoxycholic acid;
TCDCA, taurochenodeoxycholic acid; THDCA, taurohyodeoxycholic acid;
TUDCA, tauroursodeoxycholic acid.
b ND, not determined.
TABLE 5. Effects of various ions and inhibitors on BSH activity
Substancea Concn (mM) % Inhibition
Iodoacetate 3 87











a pCMBA, para-chloromercuribenzoic acid; PMSF, phenylmethylsulfonyl flu-
oride.
b Percent activation.
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three different regions (Fig. 1A). Primers B and C were used
for an internal control, primers D and E were used to detect
transcripts running from bsh to glnE, and primers A and F and
primers A and C were used to detect whether mRNA extended
upstream beyond the possible transcription start site of bsh.
First-strand cDNA synthesis was carried out both with primer
E and with primer C. The results were the same for both
cDNAs (Fig. 1B and C). In addition to the positive DNA
control, a clear signal was obtained with primers D and E,
which showed that bsh and glnE were present on the same
transcript. Products were also obtained with primers A and F
and with primers A and C, but the yields were lower. This
indicated that a transcript extended upstream from bsh, but it
may have been less abundant than the bsh-glnE transcript.
Apparently, the stem-loop structure upstream of bsh (see
above) could not eliminate transcription completely.
Selection, construction, and analysis of mutants with muta-
tions in the BSH gene. BSH-negative mutants were selected
after spontaneous mutation or after UV treatment. One spon-
taneous mutant (A3) and two UV-induced mutants (2001 and
2503) were obtained. The bsh genes of the mutants were am-
plified with a high-fidelity polymerase by using primers A and
E (Table 2 and Fig. 1) and were sequenced. Table 7 shows the
mutations in bsh (Fig. 5) and some of the properties of the
mutants. The mutation in A3 resulted in a stop codon that
resulted in deletion of 117 amino acids. The frameshift muta-
tion in 2001 replaced 50 amino acids at the C terminus with 25
amino acids of reading frame 11. Both truncated forms of
BSH were inactive, demonstrating that the C terminus is im-
portant for enzyme activity. Surprisingly, the PCR-amplified
mutated bsh gene of A3 was active in E. coli, and the complete
protein was detected in this organism (Table 7) (results not
shown). In mutant 2503 Leu-80 was replaced by Ser. This
amino acid was immediately upstream of the putative active
site residue Asn-81. In cell extracts of this B. longum mutant
and of E. coli harboring this recloned mutated bsh gene, no
activity was detected, but the protein was still present.
Biochemical characterization showed that BSH is a thiol
enzyme. Furthermore, homology studies showed that only one
Cys residue (Cys-1) is conserved in all BSH enzymes, in PVA,
and in a hypothetical protein of Bacillus subtilis (Fig. 3). The
crystal structure of PVA shows that Cys-1 plays an essential
role in the catalytic mechanism of the enzyme. Using site-
directed mutagenesis, we constructed a mutant of bsh of B.
longum in which Cys-1 was replaced by Ala (pCA-1), which
removed only the sulfur atom at this position in BSH. The
resulting mutant did not exhibit BSH activity, while the protein
was still present (Table 7); this proved that Cys-1 is essential
for BSH enzyme activity.
DISCUSSION
Characterization of B. longum SBT2928 BSH showed that
this enzyme is similar to the B. longum BB536 enzyme de-
scribed by Grill et al. (15), but the two enzymes may differ in
minor characteristics. However, Grill et al. did not provide any
genetic data about B. longum BSH; such data are provided in
this paper.
BSH is known to be very oxygen sensitive (41). The opti-
mized isolation conditions described here, in which 10 mM
DTT is included during sonication, allow workers to isolate
highly active BSH under normal atmospheric conditions. Op-
timization of the sonication conditions is crucial since even in
the presence of DTT, BSH activity is lost after extended son-
ication (Table 3).
The reported native molecular weights of BSH of different
species vary greatly. Using HPLC, which is the most accurate
method, we obtained a value for B. longum SBT2928 BSH of
FIG. 3. Alignment of BSH of various bacteria, of a hypothetical protein of
Bacillus subtilis, and PVA of Bacillus sphaericus. Asterisks, identical amino acids;
dots, similar amino acids. The boxes indicate amino acids involved in the active
site of PVA, including C-1, D-20, Y-82, N-175, and R-228 (positions based on the
B. sphaericus DNA sequence). The amino acid sequence which was determined
with purified BSH is indicated by boldface type. The enzymes examined were the
BSH of B. longum (BSHBLO), L. johnsonii BSH (BSHLBJ), L. plantarum
(BSHLBP), and C. perfringens (BSHCLP); the hypothetical protein of Bacillus
subtilis (HYPBSU); and Bacillus sphaericus PVA (PENABSP).
FIG. 4. Plasmid maps of plasmids pBH13 and pBH16, which confer BSH
activity, and two subclones. Heavy lines, plasmid pUK21; boldface restriction
sites, sites present in the insert; Plac, E. coli lacZ promoter.
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between 125,000 and 130,000, while Grill et al. (15) reported a
value of 250,000 for strain B. longum BB536 BSH. Native
molecular weights of 250,000 have also been reported for C.
perfringens and Bacteroides fragilis enzymes (13, 41). Another
C. perfringens strain has a native molecular weight of 147,000
(7). Interestingly, the molecular weight of the enzyme of Lac-
tobacillus sp. strain 100/100 (now L. johnsonii [11]) is only
105,000 or 115,000. The subunit molecular weights of BSH
have been reported to be between about 32,000 and 56,000.
Consequently, native enzymes are octamers (Bacteroides fragi-
lis [41]), hexamers (B. longum BB536 [15]), tetramers (C. per-
fringens [7, 13]), or trimers (L. johnsonii [25]). Supporting ev-
idence that the BSHs of B. longum and perhaps also all other
bacteria are tetramers comes from the high levels of homology
of all BSHs whose primary amino acid sequences are known
with PVA (42), which is a tetramer. Additionally, four of the
five putative active-site amino acids of PVA are conserved in
all BSHs, suggesting that these enzymes are also related in
their tertiary and quaternary structures (Fig. 3). How this con-
jecture can be reconciled with the previously described hetero-
trimeric structure of the well-characterized BSH of L. johnsonii
100/100 (25) is not clear, but the problem could be approached
by molecular modelling in which the three-dimensional struc-
ture of PVA is used as a template (see below).
In summary, biochemical characterization of B. longum
SBT2928 BSH has shown that this enzyme has a tetrameric
structure, a molecular weight of about 130,000, and broad
substrate specificity, is active under pH and temperature con-
ditions that occur in the human body, and requires a freeOSH
group for catalytic activity.
The following facts prove that the BSH encoded by the gene
cloned in this work and the enzyme which we purified and
biochemically characterized are identical: (i) the 1.5-kb insert
conferring BSH activity to E. coli contains an ORF for a pro-
tein whose deduced N-terminal amino acid sequence from the
third amino acid onward is identical to the deduced N-terminal
FIG. 5. Nucleotide sequence of the bsh gene region of B. longum. IR, inverted repeat; DR, direct repeat; 210, putative 210 promoter region; SD, putative SD
sequence. The N-terminal amino acid sequence determined for purified BSH is underlined. Mutations are indicated above the nucleotide sequence by boldface letters
which indicate the exchanged or inserted nucleotides. The amino acids of the supposed active site (C-1, D-20, N-81, N-172, and R-225) are double underlined.
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amino acid sequence of purified BSH, (ii) during MonoQ chro-
matography BSH activity produced in E. coli elutes at the same
salt concentration as the BSH isolated from B. longum (results
not shown), (iii) BSH activity isolated from E. coli, like B.
longum BSH activity, cross-reacts with polyclonal antibodies
raised against C. perfringens BSH, and (iv) various BSH-nega-
tive strains of B. longum SBT2928, obtained by UV-induced or
spontaneous mutagenesis, have mutations in the bsh gene. The
mutant bsh genes lead to a loss of BSH activity in E. coli
(except for mutant A3 [see below]).
From the genetic data it is clear that BSH is an intracellular
enzyme. This is consistent with the observation that no enzyme
activity was present in the supernatants of overnight cultures,
while activity was released either by sonication or other cell
disruption methods or by lysis in assays performed with whole
cells due to the lytic properties of the bile salts (data not
shown).
In RT-PCR experiments we obtained products which con-
tained almost the entire known sequence upstream of bsh,
although the yield was less. This could indicate that bsh is
transcribed both by its own promoter and to a lesser degree
from an upstream region. Another piece of supporting evi-
dence that bsh could have its own promoter comes from the
fact that BSH activity is found in pBH13 and related constructs
in which bsh is cloned in the direction opposite that of the lac
promoter in these plasmids. Primer extension experiments
have failed so far and need to be carried out to definitely
establish whether bsh has a promoter directly upstream of its
coding sequence.
Alignment of the 39 end of the 16S rRNA of bifidobacteria
with the regions upstream of the ATG start codon of all known
bifidobacterial genes revealed that only the AGG of the ca-
nonical GGAGG sequence (54) is conserved (Table 6). Also,
bsh is preceded by two possible SD sequences with central
AGG motives. This could imply that the translation start in
bifidobacteria has slightly different requirements than the
translation start in, for instance, Bacillus subtilis (51, 54). The
gene following bsh, glnE, does not have this AGG motive and
has only a very short putative SD sequence (GGA) that has a
free energy of 27.2 kcal, which is very low for the gram-
positive translation machinery. However, the stem-loop struc-
ture in front of glnE might facilitate a translational restart by
TABLE 6. Alignment of the regions immediately upstream of the ATG start codons of six Bifidobacterium genes and B. longum BSH with the
16S rRNA 39-terminal consensus sequence
Organism Gene Sequence around the start codona Free energy(kcal) Distance
b
B. breve (E05040)c b-Galactosidase gene ATATTTATTCATTAAAGGAACAGCATCATC ATGGAACATCGCGAAT 212.4 12
39 tctttcctccac tagg 59
B. breve b-D-Glucosidase gene CGGCGCCAACTAGAAAGGAATCACCG ATGACGATGATCTTCC 216.2 8
39 tctttcctccactagg 59
B. adolescentis (AF124596) a-Galactosidase gene AAGAATCGCAAGAAAAGGATGCTGCA ATGACGCTCATTCAGA 211.8 8
39 tctttcctccactagg 59
B. breve (AF094756) recA CATACGACTTCGATAAGGAGAAGATC ATGGCACTTGAGACCA 218.2 8
39 tctttcctccactagg 59
B. asteroides (Y11549) recA GGCCGATCACTGAAAAGGAG TGATTAGCA ATGACCGATTCTACCG 219.4 11
39 tctttcctccactagg 59
B. longum ldh ACCGCCTTTGAAGAGAGGTTCATCCATC ATGGCGGAAACTACCG 217.2 10
39 tctttcctccac tagg 59
B. longum bsh AACCAAAGCGATGGAAGGGAGTCCGTT ATGTGCACTGGTGTCC 212.4 9
39 tctttcctccactagg 59d
B. longum bsh AACCAAAGCGATGGAAGG GAGTCCGTT ATGTGCACTGGTGTCC 221.6 9
39 tctttcc tccact agg 59d
a The sequence of the 39 end of Bifidobacterium 16S ribosomal DNA is 39 tcttcctccactagg 59, shown in lowercase letters under each SD region. The box indicates the
central AGG motif of the SD region in bifidobacteria.
b Distance (in nucleotides) between ATG and the core AGG sequence in the SD region.
c The numbers in parentheses are GenBank nucleotide sequence accession numbers.
d Possible alignment of the 39 end of the 16S ribosomal DNA with the upstream region of bsh.
TABLE 7. Overview of bsh mutants
Mutant Mutation Activity in B. longum Activity in E. coli Protein in B. longuma Protein in E. colia
A3 Spontaneous mutant, G-A transition
creating a stop codon in place of
amino acid 200 (Trp), deletion of
117 amino acids
No activity detected Activity No protein detected Protein of original size
2503 UV-induced T-C transition causing
Leu80Ser exchange
No activity detected No activity detected Protein present Protein present
2001 Insertion of G after GG of Gly-267,
causing a frameshift and loss of
the last 50 amino acids
No activity No activity No protein No protein
C1Ab Site-directed mutagenesis of TG of
Cys-1 to GC, resulting in Cys1Ala
exchange
No activity Protein present
a The presence of BSH was determined by Western blotting with polyclonal antibodies.
b Mutation present only in bsh cloned in E. coli.
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bringing the stop codon of bsh close to the start codon of glnE
(54).
B. longum BSH exhibits high levels of homology with BSH of
various lactobacilli and C. perfringens, with a hypothetical pro-
tein of Bacillus subtilis, and with PVA of Bacillus sphaericus
(42). Recently, the crystal structure of PVA has been deter-
mined. A homology analysis of BSH and PVA revealed that
four of the five amino acids at the active site of PVA are
conserved in BSH, while Tyr-82 is replaced by Asn-81 in BSH.
The catalytically important part of Tyr-82 in PVA is the NH
group of the peptide bond. Therefore, probably, Tyr-82 could
be replaced easily by another amino acid if the NH group is
kept in the right position (for BSH, Asn-81). The fact that
Asn-81 is conserved in the different BSHs could have to do
with different steric requirements for binding of bile salts com-
pared to binding of penicillin V. The striking similarities in the
primary structure and in the active-site amino acids indicate
that B. longum BSH and all other known BSHs belong to the
same group of N-terminal nucleophile hydrolases. Therefore,
the secondary and tertiary structures are probably also very
similar. It is not clear, however, how much the tertiary struc-
ture is conserved in L. johnsonii 100/100 BSH, for which a
heterotrimeric structure has been proposed (26).
Downstream of bsh a gene with a very high level of homol-
ogy to glutamine synthetase adenylyltransferase (glnE) was
found. This enzyme transfers adenylyl residues from ATP to
glutamine synthetase and is part of the nitrogen regulation
cascade (27, 53) in E. coli and, by analogy, probably also in
Haemophilus influenzae, various mycobacteria, and pseudo-
monads. The intergenic region between bsh and glnE is rather
short and lacks a strong termination signal. RT-PCR experi-
ments have shown that the two genes are transcriptionally
coupled, indicating that in B. longum bsh is part of an operon.
The extent of this operon is not known, since only the 59 part
of glnE has been cloned and the transcript extends upstream of
bsh (see above). Homology searches for the region 250 bp
upstream of bsh produced no results. This genetic organization
is different from that found in two Lactobacillus strains, while
no adjacent sequences have been found for C. perfringens bsh
(7). In L. plantarum bsh is monocistronic (6), and in L. johnso-
nii bsh is preceded by two genes that encode bile salt transport
systems, but the exact extent of this operon is not known (11).
The combination of bsh and glnE in one operon is rather
surprising, since there is no obvious functional relationship
between the two enzymes. However, the coupling of bsh to a
gene of the nitrogen regulation cascade reminds us of the
hypothesis that hydrolysis of bile salts makes the amino acid
nitrogen atoms of the released amino acids available for cells
(18, 52).
Interestingly, the A3 bsh mutation, which did not produce a
protein in B. longum, did produce activity and a protein in E.
coli (Table 7). Apparently, in E. coli the stop codon created
was overread in a translational readthrough process (12),
which resulted in an intact molecule. One UV-induced muta-
tion, the mutant 2503 bsh mutation, resulted in a leucine-to-
serine change at the position next to active site residue Asn-81
which probably resulted in a substantial steric change which led
to inactivation of the protein. With the other UV-induced
mutation, the mutant 2001 bsh mutation, 50 C-terminal amino
acids were removed, activity was lost, and there was rapid
turnover of BSH, as the protein could not be detected in B.
longum or in E. coli.
The N-terminal amino acid sequence determined for puri-
fied BSH did not include a Met residue. This means that
formylmethionyl is processed and that Cys is the first amino
acid of the mature protein. These findings are identical to
findings obtained with PVA, in which Cys-1 plays a central role
at the active site (42). The important role of Cys-1 was con-
firmed by the finding that a change of Cys-1 to Ala led to
complete inactivation of BSH.
The biochemical and genetic data reported in this paper
provide a sound foundation for investigating the role of bile
salt hydrolysis in both the bacterial producers and their mam-
malian hosts. Furthermore, we created BSH-negative mutants
which can be used in animal experiments and human studies to
investigate the effects of enhanced bile salt deconjugation in
the small intestine and to evaluate in a mechanistic way the
hypothesis that BSH lowers serum cholesterol.
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